Literature DB >> 24048784

Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer.

Hun Jung1, Han Hong Lee, Kyo Young Song, Hae Myung Jeon, Cho Hyun Park.   

Abstract

BACKGROUND: The seventh edition of the American Joint Committee on Cancer (AJCC) TNM classification for gastric cancer was published in 2010 and included major revisions. The aim of the current study was to evaluate the validity of the seventh edition TNM classification for gastric cancer based on an Asian population.
METHODS: A total of 2916 gastric cancer patients who underwent R0 surgical resection from 1989 through 2008 in a single institute were included, and were analyzed according to the seventh edition of the TNM classification for validation.
RESULTS: When adjusted using the seventh edition of the TNM classification, upstaging was observed in 771 patients (26.4%) and downstaging was observed in 178 patients (6.1%) compared with the sixth edition of the TNM classification. The relative risk (RR) of seventh edition pT classification was found to be increased with regular intensity compared with the sixth edition pT classification. The RR of seventh edition pN classification was found to be increased with irregular intensity compared with the sixth edition pN classification. In survival analysis, there were significant differences noted for each stage of disease, but only a marginal difference was demonstrated between stage IA and stage IB (P = .049). In the hybrid TNM classification, which combines the seventh edition pT classification and the sixth edition pN classification, both pT and pN classifications demonstrated a more ideal distribution of the RR, and 5-year survival rates also showed a significant difference for each stage (P <.01).
CONCLUSIONS: The seventh edition of the TNM classification was considered valid based on the results of the current study. However, the hybrid TNM classification, comprised of a combination of the seventh edition pT classification and sixth edition pN classification, should be considered for the next edition.
Copyright © 2011 American Cancer Society.

Entities:  

Keywords:  gastric cancer; hybrid TNM staging system; seventh edition American Joint Committee on Cancer TNM staging system; validation

Mesh:

Year:  2011        PMID: 24048784     DOI: 10.1002/cncr.25778

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  41 in total

1.  Superiority of the 8th edition of the TNM staging system for predicting overall survival in gastric cancer: Comparative analysis of the 7th and 8th editions in a monoinstitutional cohort.

Authors:  Hao Wang; Weihong Guo; Yanfeng Hu; Tingyu Mou; Liying Zhao; Hao Chen; Tian Lin; Tuanjie Li; Jiang Yu; Hao Liu; Guoxin Li
Journal:  Mol Clin Oncol       Date:  2018-07-26

Review 2.  Preoperative staging of nodal status in gastric cancer.

Authors:  Felix Berlth; Seung-Hun Chon; Mickael Chevallay; Minoa Karin Jung; Stefan Paul Mönig
Journal:  Transl Gastroenterol Hepatol       Date:  2017-02-07

3.  TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion.

Authors:  Zi-Zhen Zhang; Rong Hua; Jun-Feng Zhang; Wen-Yi Zhao; En-Hao Zhao; Lin Tu; Chao-Jie Wang; Hui Cao; Zhi-Gang Zhang
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

Review 4.  Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Authors:  Jizhun Zhang; Yangbing Zhou; Kewei Jiang; Zhanlong Shen; Yingjiang Ye; Shan Wang
Journal:  Tumour Biol       Date:  2014-04-03

5.  Recurrence of a pT2N0cM0 Lower Third Gastric Cancer with No. 6 Lymph Node Micrometastasis after R0 Extended Surgery. Should Adjuvant Therapy be Performed in Conventionally Node-Negative but Micrometastasis-Positive pT2 Gastric Cancer?

Authors:  Konstantinos Blouhos; Konstantinos A Boulas; Konstantinos Tsalis; Nikolaos Barettas; Michail Aftzoglou; Anestis Hatzigeorgiadis
Journal:  J Gastrointest Cancer       Date:  2017-03

6.  Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery.

Authors:  Etsuro Bando; Rie Makuuchi; Masanori Tokunaga; Yutaka Tanizawa; Taiichi Kawamura; Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-09-01       Impact factor: 7.370

7.  Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.

Authors:  Zhai Ertao; Chen Jianhui; Wang Kang; Ye Zhijun; Wu Hui; Chen Chuangqi; Qin Changjiang; Chen Sile; He Yulong; Cai Shirong
Journal:  Tumour Biol       Date:  2016-07-29

Review 8.  Recent developments and innovations in gastric cancer.

Authors:  Mehmet Mihmanli; Enver Ilhan; Ufuk Oguz Idiz; Ali Alemdar; Uygar Demir
Journal:  World J Gastroenterol       Date:  2016-05-07       Impact factor: 5.742

9.  Osteopontin, E-cadherin, and β-catenin expression as prognostic biomarkers in patients with radically resected gastric cancer.

Authors:  Maria Di Bartolomeo; Filippo Pietrantonio; Alessandro Pellegrinelli; Antonia Martinetti; Luigi Mariani; Maria Grazia Daidone; Emilio Bajetta; Giuseppe Pelosi; Filippo de Braud; Irene Floriani; Rosalba Miceli
Journal:  Gastric Cancer       Date:  2015-04-11       Impact factor: 7.370

10.  Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.

Authors:  Zhai Ertao; Chen Jianhui; Chen Chuangqi; Qin Changjiang; Chen Sile; He Yulong; Cai Shirong; Wu Hui
Journal:  Tumour Biol       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.